VCM
IBB icon

Vigilant Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Vigilant Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-200
Closed -$26K – 469
2023
Q1 		$26K Buy
+200
New +$26.2K ﹤0.01% 320
2020
Q1 		– Sell
-3,555
Closed -$428K – 375
2019
Q4 		$428K Hold
3,555
– – 0.05% 80
2019
Q3 		$354K Sell
3,555
-3,020
-46% -$316K 0.05% 86
2019
Q2 		$717K Hold
6,575
– – 0.1% 59
2019
Q1 		$735K Sell
6,575
-31,606
-83% -$3.47M 0.1% 61
2018
Q4 		$3.68M Sell
38,181
-57,206
-60% -$6.07M 0.58% 44
2018
Q3 		$11.6M Sell
95,387
-80
-0.1% -$9.42K 1.55% 36
2018
Q2 		$10.5M Sell
95,467
-4,133
-4% -$442K 1.52% 36
2018
Q1 		$10.6M Buy
99,600
+1,111
+1% +$123K 1.51% 36
2017
Q4 		$10.5M Buy
98,489
+5,681
+6% +$607K 1.38% 39
2017
Q3 		$10.3M Buy
92,808
+1,005
+1% +$107K 1.54% 34
2017
Q2 		$9.49M Buy
91,803
+5,565
+6% +$548K 1.54% 28
2017
Q1 		$8.43M Buy
86,238
+1,680
+2% +$161K 1.47% 34
2016
Q4 		$7.48M Sell
84,558
-345
-0.4% -$31.4K 1.32% 41
2016
Q3 		$8.19M Sell
84,903
-1,311
-2% -$125K 1.45% 29
2016
Q2 		$7.39M Sell
86,214
-870
-1% -$78.1K 1.42% 36
2016
Q1 		$7.57M Sell
87,084
-15,276
-15% -$1.37M 1.51% 30
2015
Q4 		$11.5M Sell
102,360
-2,565
-2% -$278K 2.34% 11
2015
Q3 		$10.6M Buy
104,925
+1,746
+2% +$209K 2.12% 14
2015
Q2 		$12.7M Sell
103,179
-1,170
-1% -$140K 2.3% 11
2015
Q1 		$11.9M Buy
104,349
+1,044
+1% +$115K 2.25% 11
2014
Q4 		$10.4M Buy
103,305
+4,590
+5% +$446K 2.07% 13
2014
Q3 		$9M Buy
98,715
+3,921
+4% +$344K 1.95% 19
2014
Q2 		$8.12M Buy
94,794
+51,945
+121% +$4.09M 1.8% 20
2014
Q1 		$3.38M Buy
+42,849
New +$3.57M 0.8% 47

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Vigilant Capital Management's IBB Position: Q2 2023 in Review

Vigilant Capital Management sold out of iShares Biotechnology ETF (IBB) in Q2 2023, closing a stake of 200 shares — an estimated $26K sold.

Vigilant Capital Management first reported a position in IBB in Q1 2014 and held it in 25 quarters. The position peaked at $12.7M in Q2 2015. 843 funds tracked by Wall St. Rank hold IBB as of Q2 2023.

  • Vigilant Capital Management reported no remaining iShares Biotechnology ETF position as of Q2 2023 after selling out during the quarter.
  • Vigilant Capital Management sold 200 iShares Biotechnology ETF shares in Q2 2023, an estimated $26K.
  • Vigilant Capital Management first reported a position in iShares Biotechnology ETF in Q1 2014 and held it in 25 quarters.
  • Vigilant Capital Management's iShares Biotechnology ETF position peaked at $12.7M in Q2 2015.
  • 843 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2023.

Based on Vigilant Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.